• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Diagnosis
    • Glossary
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Voice Preservation
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven (Off-Label) Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition and Swallowing
      • Occupational Therapy and Activities of Daily Living
      • Physiotherapy and Mobility
      • Respiratory Care
      • Speech Therapy and Communication
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • AB Science – Masitinib
      • BrainStorm Cell Therapeutics – NurOwn
      • Clene Nanomedicine – CNM-Au8
      • ILB – Tikomed
      • Kadimastem – AstroRx
      • Mitsubishi Tanabe Pharma America – Oral Edaravone
      • Neuronata-R/Lenzumestrocel
      • NeuroSense – PrimeC
      • Neuvivo – NP001
      • Prilenia Therapeutics – Pridopidine
      • SOD1 Therapies & Trials
      • SPG302
      • T Regulatory Cell Therapies
      • Ulefnersen – Ionis Pharmaceuticals
    • Approved Drugs
      • Nuedexta
      • Radicava/Edaravone
      • Riluzole/Tiglutik
      • Rozebalamin/Methylcobalamin
      • Tofersen/Qalsody
    • Drugs No Longer in Development
      • Amylyx – AMX0035
      • Collaborative Medicinal Development – CuATSM
      • Cytokinetics – Reldesemtiv
      • Orphazyme – Arimoclomol
      • TUDCA Trial
  • Support for Health Professionals
    • Breaking the News in ALS/MND
  • Events/Programs
    • Calendar of Events/Programs
    • Global Day Calendar
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • International Symposium
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Councils, Forums & Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Newsletter Archive
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • Members
    • Member Registration
    • Forgot Password

History

The International Alliance of ALS/MND Associations was founded in 1992 by a small group of national ALS/MND associations that shared a common goal: to strengthen support for people living with ALS/MND by working together across borders.

What began as a collaborative network has grown into a global community of more than 80 member associations in over 40 countries. Today, the Alliance connects organizations, healthcare professionals, researchers, people living with ALS/MND, caregivers, and advocates to improve care, advance research, and build a world free of ALS/MND.

How the Alliance Began

Based on recollections by Mavis Gallienne, Wendy Abrams, Rodney Harris, and Peter Cardy (December 2012).

The idea for an international ALS/MND network emerged in 1987–1988, shortly after Peter Cardy became Chief Executive Officer of the MND Association of England, Wales and Northern Ireland.

The Association launched an annual international research meeting—the event that would later become the International Symposium on ALS/MND. Originally titled, “Who Is Out There Researching Into MND?”, the meeting brought together researchers and representatives from ALS/MND organizations around the world.

As these meetings grew, so did conversations about creating an international organization that could connect national associations, strengthen support for people living with ALS/MND, and encourage global research collaboration. Those discussions led to the founding of the International Alliance of ALS/MND Associations.

The Founding of the Alliance

The Alliance was formally established during a meeting held in Solihull, Birmingham, England, from November 4–6, 1992. Representatives from ALS/MND associations agreed to create an international organization dedicated to collaboration, shared learning, advocacy, and research.

Read the official notes from the founding meeting (PDF).

Marking 30 Years

In 2022, the Alliance celebrated its 30th anniversary with a video reflecting on its history and the people who helped build the global ALS/MND community.

Growing a Global Community

Over the past three decades, the Alliance has evolved from a network centred on an annual meeting into a year-round global organization supporting collaboration, education, advocacy, and research.

Membership has expanded to more than 80 organizations across 40+ countries, with increasing engagement in Latin America, Africa, South Asia, and other regions where ALS/MND services and research infrastructure continue to develop. Regional collaborations, including ALS Africa and ELATAM, have strengthened local leadership and knowledge sharing.

The Alliance has also launched initiatives that bring more voices into the global ALS/MND community. These include the Patient Fellows Program, which supports people living with ALS/MND and caregivers to participate in international research discussions; the Allied Professionals Forum, which connects healthcare professionals worldwide; and the SEED Grant Program, which provides early-stage funding to strengthen ALS/MND research capacity in low- and middle-income countries.

In 2025, the Alliance published the ALS/MND Health Literacy Map, a global framework that identifies the information and support people living with ALS/MND, caregivers, and families need throughout the disease journey. The framework now guides much of the Alliance’s education and communications work.

Today, the Alliance continues to unite organizations around a shared vision of a world free of ALS/MND. Its 2026–2028 Strategic Plan focuses on improving quality of life, expanding inclusion, raising global awareness, strengthening research collaboration, building organizational capacity, and growing the international ALS/MND community.

Alliance Chairs

The following individuals have served as Chair of the International Alliance of ALS/MND Associations:

  • Eithne Frost, Irish MND Association
  • Mavis Gallienne, MND Australia, UK
  • Wendy Abrams, Les Turner ALS Foundation, USA
  • Diane Heron, MND Association of South Africa
  • Rod Harris, MND Victoria, Australia
  • Gudjon Sigurdsson, MND Iceland
  • Jeffrey Deitch, ALS Hope Foundation, USA
  • Carol Birks, MND Australia
  • Steve Bell, MND Association, UK
  • Calaneet Balas, The ALS Association, USA (2018–2025)
  • Tammy Moore, ALS Society of Canada (2025–present)

Primary Sidebar

About

  • Who We Are
  • Board of Trustees
  • Councils, Forums & Committees
    • PALS and CALS Advisory Council
    • Scientific Advisory Council
    • Advocacy and Public Policy Forum
    • Research Directors Forum
    • Governance Committee
    • Finance Committee
  • Staff
  • History
  • Newsletter Archive
    • Newsletters
    • Meetings
  • Awards

  • Xian-Zhang Niu, China

    Xian-Zhang Niu, China

  • Rosie Riley, USA

    Rosie Riley, USA

  • Jon Newsome, USA

    Jon Newsome, USA

  • Mikey Stone, ALS

    Mikey Stone, ALS

  • Fabrice Kamp, Germany

    Fabrice Kamp, Germany

  • Danny Reviers, Belgium

    Danny Reviers, Belgium

  • Sharon Corosanite, USA

    Sharon Corosanite, USA

  • Claudia Cominetti, Italy

    Claudia Cominetti, Italy

  • Yannick Richard, Canada

    Yannick Richard, Canada
    yannickrichard

  • Dick Dayton, USA

    Dick Dayton, USA

  • Ana María Zavala, Mexico

    Ana María Zavala, Mexico

  • Mirca Bersani, Italy

    Mirca Bersani, Italy
    MircaBersani

  • Alejandro Aquino, Argentina

    Alejandro Aquino, Argentina

  • Philip Brindle, England

    Philip Brindle, England

  • Seckin McGuirk, England

    Seckin McGuirk, England

  • Maurice Leclerc, Canada

    Maurice Leclerc, Canada

  • Anthony Lynch, Australia

    Anthony Lynch, Australia

  • Ismail Gokcek, Turkey

    Ismail Gokcek, Turkey
    ismail_gokcek_alsmnd_tr

  • Ailsa Malcolm-Hutton, UK

    Ailsa Malcolm-Hutton, UK

  • Susan Anderson, USA

    Susan Anderson, USA

  • Motoko Ogasawara, Japan

    Motoko Ogasawara, Japan

  • Armando González Gómez, Colombia

    Armando González Gómez, Colombia

  • Elkin Ramiro Gaviria Muñoz, Colombia

    Elkin Ramiro Gaviria Muñoz, Colombia

  • Joy Blakeley, Australia

    Joy Blakeley, Australia

  • Liam Dwyer, England

    Liam Dwyer, England

  • Eric Von Schaumburg, USA

    Eric Von Schaumburg, USA

  • Enzo Maccarrone, Italy

    Enzo Maccarrone, Italy

  • Frank Taylor, USA

    Frank Taylor, USA

  • Orly Dichoso, Canada

    Orly Dichoso, Canada

  • Timothy Holman, Switzerland

    Timothy Holman, Switzerland

  • John Sweeney, USA

    John Sweeney, USA

  • Jose Espinosa, Argentina

    Jose Espinosa, Argentina

  • Marcelo Farinelli, Brazil

    Marcelo Farinelli, Brazil

  • Len Johnrose, England

    Len Johnrose, England

  • Mary Thomas, Australia

    Mary Thomas, Australia

  • Soledad Rodriguez, Spain

    Soledad Rodriguez, Spain

  • Glen Victor Peters, Australia

    Glen Victor Peters, Australia

  • Aida Trzmiel de Guterman, Argentina

    Aida Trzmiel de Guterman, Argentina

  • Wendy Hendrickson, USA

    Wendy Hendrickson, USA

  • Animesh Kumar, India

    Animesh Kumar, India

  • Hollister

    Hollister
    hollister

  • Steven Gallagher, Canada

    Steven Gallagher, Canada

  • Kirsty Gerlach, New Zealand

    Kirsty Gerlach, New Zealand

  • David Watson, Scotland

    David Watson, Scotland

  • Shay Rishoni, Netherlands

    Shay Rishoni, Netherlands

  • Orlando Ruiz, Colombia

    Orlando Ruiz, Colombia

  • Leon Ryba, Argentina

    Leon Ryba, Argentina

  • Guido De Mets, Belgium

    Guido De Mets, Belgium

  • Wiebke Braach, Germany

    Wiebke Braach, Germany

  • Purningam Jacob, India

    Purningam Jacob, India

Learn more about the March of Faces

Footer

Stay connected to the global ALS/MND community.

Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

 
This field is for validation purposes and should be left unchanged.
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube
Return to top of page

Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login